BioMembrOS
Financiado
Biomimetic Membranes for Organ Support
Acute respiratory distress syndrome (ARDS) is currently seen in huge numbers of patients worldwide due to the COVID-19 pandemic,but also before that, respiratory diseases were the third largest cause of death in the EU. Current th...
Acute respiratory distress syndrome (ARDS) is currently seen in huge numbers of patients worldwide due to the COVID-19 pandemic,but also before that, respiratory diseases were the third largest cause of death in the EU. Current therapy for respiratory failureincludes mechanical ventilation and extracorporeal membrane oxygenation (ECMO) both associated with high morbidity andmortality. In ECMO devices the functionality of the lungs tissue membranes that are responsible for gas exchange during breathing isusually taken over by bundles of synthetic cylindrical hollow fiber membranes. Geometries and transport characteristics of standardhollow fiber membranes are not suitable for re-building the structurally complex and dynamic contracting microstructure of themammalian lung and consequently, artificial devices to assist/replace respiration still face major limitations in size, flow characteristicsand hemocompatibility that impede the development of efficient intracorporeal devices. In BioMembrOS, we want to follow agroundbreaking new biomimetic approach, and replicate main characteristics of the most effective respiration found in vertebrates,mainly birds and fish, in order to develop membrane structures that will serve as key elements for a novel generation of artificialrespiration devices. To reach this goal, we will a) optimize geometry of the membrane structure by mimicking microstructure of thegills of fish to increase outer surface per membrane area, mimicking globular shape of the gas transporting inner lumen andinterconnected arrangement of membrane fibers of avian respiration; b) design and control flow characteristics and boundary layerapplying μPIV experimental flow investigations and structural design optimization; c) design and synthesize bi-soft segmentpolyurethane membranes with increased hemocompatibility and gas permeability with phase inversion; and d) verify and benchmarkthe boosted mass transfer capabilities by in-vitro blood tests
ver más
Duración del proyecto: 41 meses
Fecha Inicio: 2024-01-01
Fecha Fin: 2027-06-30
Fecha Fin: 2027-06-30
Línea de financiación: concedida
El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-01-01
Línea de financiación objetivo
El proyecto se financió a través de la siguiente ayuda:
HORIZON-EIC-2023-PATHFINDEROPEN-01-01:
EIC Pathfinder Open
Cerrada
hace 1 año
Presupuesto
El presupuesto total del proyecto asciende a
3M€
Líder del proyecto
TECHNISCHE UNIVERSITAET WIEN
No se ha especificado una descripción o un objeto social para esta compañía.
Perfil tecnológico
TRL
4-5
Perfil tecnológico
TRL
4-5